The BioFriend BioMask reduces the bio-burden of germs on the mask, effectively reducing the wearer’s exposure to germs and reducing the risk of healthcare-associated infections. Additionally, in independent laboratory tests, the BioFriend BioMask facemask inactivated 99.99 percent of tested pandemic and seasonal strains of influenza A and B viruses in five minutes.
Read the company news release about BioFriend BioMask.
Related Articles on Infection Control:
Survey: 64% of Americans Don’t Believe They’re Safer From Germs in a Hospital
Contrast Agent Could Help Detect Infections Through Imaging
Study: MRSA Bundle Implementation Needs the Right Multidisciplinary Team
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit